Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19
Clinical trial NCT04779879 · COMPLETED
Trial details
- NCT number
- NCT04779879
- Sponsor
- Vir Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-18
- Primary completion
- 2021-08-20
- Enrollment
- 354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.